A couple of snippets for those not wanting to clicky clicky linky linky:
In a move to bolster innovation and allow investors a chance to participate in the new age of medicine, MindMed listed on the Nasdaq, a brand that’s supported firms like Apple Inc (NASDAQ:AAPL), Alphabet Inc (NASDAQ:GOOGL), and Microsoft Corporation (NASDAQ:MSFT), at their earliest stages. “It was definitely a long process to get here,” Rahn noted. “Because of the high listing standard, Nasdaq is a great place to interact with institutional investors and ultimately enable us to allocate capital to these unmet medical needs in mental health.”
Aside from validation, diversification is a key barrier to investing for smart-money investors and institutions. Institutional investors, especially in junior pharma, are looking to mitigate risk and weight according to diversity across a few key metrics, according to O’Leary.
"...could achieve a superior market cap because of its diversification"
IHL Price at posting:
31.3¢ Sentiment: Buy Disclosure: Held